FDA Approved: IRBESARTAN — Supplemental Application (AvKARE)

View source ↗

Summary

FDA approves AvKARE's supplemental application for IRBESARTAN, enabling continued marketing of the generic irbesartan product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension

Drugs mentioned

• Irbesartan (irbesartan)

Snippet

SUPPL AP for IRBESARTAN (IRBESARTAN)